Evidence map›Paper›PMID 29089023›Full record

ArticleBMC nephrology2017

Phenotype variability in a large Spanish family with Alport syndrome associated with novel mutations in COL4A3 gene.

C Cervera-Acedo, A Coloma, E Huarte-Loza, M Sierra-Carpio, E Domínguez-Garrido

Open access · goldAbstract read
In one paragraph

Article in BMC nephrology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Identification of Four NovelFrontiers in genetics · 2022
    Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

C Cervera-AcedoMolecular Diagnostics Unit, Center for Biomedical Research (CIBIR), Fundación Rioja Salud, C/Piqueras 98, 26006, Logroño, La Rioja, Spain.
A ColomaDepartment of Nephrology, San Pedro Hospital, Logroño, La Rioja, Spain.
E Huarte-LozaDepartment of Nephrology, San Pedro Hospital, Logroño, La Rioja, Spain.
M Sierra-CarpioDepartment of Nephrology, San Pedro Hospital, Logroño, La Rioja, Spain.
E Domínguez-GarridoMolecular Diagnostics Unit, Center for Biomedical Research (CIBIR), Fundación Rioja Salud, C/Piqueras 98, 26006, Logroño, La Rioja, Spain. edominguez@riojasalud.es.
Hospital San Pedro · ESCenter for Biomedical Research of La Rioja · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlport syndrome is an inherited renal disorder characterized by glomerular basement membrane lesions with hematuria, proteinuria and frequent hearing defects and ocular abnormalities. The disease is associated with mutations in genes encoding α3, α4, or α5 chains of type IV collagen, namely COL4A3 and COL4A4 in chromosome 2 and COL4A5 in chromosome X. In contrast to the well-known X-linked and autosomal recessive phenotypes, there is very little information about the autosomal dominant. In view of the wide spectrum of phenotypes, an exact diagnosis is sometimes difficult to achieve.

methodsWe investigated a Spanish family with variable phenotype of autosomal dominant Alport syndrome using clinical, histological, and genetic analysis.

resultsMutational analysis of COL4A3 and COL4A4 genes showed a novel heterozygous mutation (c. 998G > A; p.G333E) in exon 18 of the COL4A3 gene. Among relatives carrying the novel mutation, the clinical phenotype was variable. Two additional COL4A3 mutations were found, a Pro-Leu substitution in exon 48 (p.P1461L) and a Ser-Cys substitution in exon 49 (p.S1492C), non-pathogenics alone.

conclusionCarriers of p.G333E and p.P1461L or p.S1492C mutations in COL4A3 gene appear to be more severely affected than carriers of only p.G333E mutation, and the clinical findings has an earlier onset. In this way, we could speculate on a synergistic effect of compound heterozygosity that could explain the different phenotype observed in this family.

Indexed as

PhenotypeAdultAgedAutoantigensCollagen Type IVFemaleGenetic VariationHumansMaleMiddle AgedMutationNephritis, HereditaryPedigreeSpainAutoantigensCollagen Type IVtype IV collagen alpha3 chainAlport syndromeCOL4A3 geneMicrohematuriaProteinuria, genotype-phenotype correlation

Identifiers

PMID29089023
PMCPMC5664579
OpenAlexW2765945629

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.